Astrazeneca Share News (AZN)

GSK selects Burberry's Brown as its first female CFO

Brown to join GSK in April

*

Valneva in talks with potential partner on second-gen COVID-19 vaccines

PARIS, Sept 26 (Reuters) - French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets new variants of the disease, sending its shares up.

TOP NEWS: GSK names Burberry's Julie Brown as new CFO from May

(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire.

TOP NEWS: AstraZeneca's Ultomiris approved in EU for myasthenia gravis

(Alliance News) - AstraZeneca PLC on Friday said its Ultomiris drug has been approved in the EU to treat myasthenia gravis, a condition which causes muscle weakness.

LONDON BRIEFING: Smiths annual revenue rises; Made.com up for sale

(Alliance News) - European markets are set to end a difficult week in decent fashion on Friday, as investors take onboard a series of hawkish central bank moves.

AstraZeneca's gMG treatment receives EU approval

(Sharecast News) - Drugmaker AstraZeneca said on Friday that Ultomiris, its long-acting C5 inhibitor, had received EU approval to be used in the treatment of adult patients with generalised myasthenia gravis, a rare autoimmune neuromuscular disease.

TOP NEWS: AstraZeneca's Lynparza approved in China for ovarian cancer

(Alliance News) - AstraZeneca PLC on Thursday, along with pharmaceutical peer Merck & Co Inc, said that Lynparza has been approved in China for the maintenance treatment of adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer.

LONDON BRIEFING: Lower call; JD Sports suffers interim profit fall

(Alliance News) - Stocks in London are set to open lower on Thursday, ahead of a major interest rate decision by the Bank of England and a day after the US Federal Reserve settled for another three-quarter-point rate hike.

WPP grows in Latin America with JeffreyGroup acquisition

(Alliance News) - Advertising company WPP PLC said it has boosted its Latin American presence with a deal to acquire JeffreyGroup.

TOP NEWS: AstraZeneca's Tezpire approved in EU for severe asthma

(Alliance News) - AstraZeneca PLC on Wednesday its Tezpire severe asthma treatment has been approved in the EU by the European Commission.

LONDON BRIEFING: Flat call; Aveva gets offer from Schneider Electric

(Alliance News) - Stocks in London are set to open unchanged on Wednesday ahead the US Federal Reserve's interest rate decision later in the day and the Bank of England's decision on Thursday.

AstraZeneca's severe asthma treatment gets EU approval

(Sharecast News) - Drugmaker AstraZeneca said on Wednesday that Tezspire, its severe asthma treatment, had received EU approval for use as an add-on maintenance treatment in patients 12 years and older.

TOP NEWS: AstraZeneca's Evusheld approved in EU for Covid-19 treatment

(Alliance News) - AstraZeneca PLC on Tuesday said its Evusheld treatment for Covid-19 has been approved for use in the EU.

LONDON BRIEFING: Haleon reports double-digit revenue growth

(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II.

AstraZeneca's Covid-19 antibody combination receives EU approval

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Evusheld, its long-acting antibody combination, had been granted approval for the treatment of adults and adolescents with Covid-19 in the European Union.